循环 MicroRNAs 在急性肺栓塞中的诊断价值

DOI: doi:10.7507/1671-6205.201704033

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	1. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2014, 35(45): 3033-3069.
[2]	2. Xu Q, Huang K, Zhai Z, et al. Initial thrombolysis treatment compared with anticoagulation for acute intermediate-risk pulmonary embolism: a meta-analysis. J Thorac Dis, 2015, 7(5): 810-821.
[3]	3. Ince O, Altintas N, Findik S, et al. Risk stratification in submassive pulmonary embolism via alveolar-arterial oxygen gradient. Hippokratia, 2014, 18(4): 333-339.
[4]	4. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med, 2010, 363(3): 266-274.
[5]	5. Huisman MV, Klok FA. How I diagnose acute pulmonary embolism. Blood, 2013, 121(22): 4443-4448.
[6]	6. Moores LK, King CS, Holley AB. Current approach to the diagnosis of acute nonmassive pulmonary embolism. Chest, 2011, 140(2): 509-518.
[7]	7. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol, 2005, 6(5): 376-385.
[8]	8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297.
[9]	9. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 2006, 6(4): 259-269.
[10]	10. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer, 2006, 6(11): 857-866.
[11]	11. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 2008, 105(30): 10513-10518.
[12]	12. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008, 18(10): 997-1006.
[13]	13. Montani F, Bianchi F. Circulating cancer biomarkers: the macro-revolution of the micro-RNA. EBioMedicine, 2016, 5: 4-6.
[14]	14. D’Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J, 2010, 31(22): 2765-2773.
[15]	15. 崔玲, 秦永文. 循环血微小 RNA 作为急性肺动脉栓塞新型生物标志物的实验研究. 上海: 第二军医大学(学位论文), 2015.
[16]	16. Xiao J, Jing ZC, Ellinor PT, et al. MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med, 2011, 9: 159.
[17]	17. 王亚平, 赵振, 张恒, 等. 血浆 MicroRNA-134 在西宁地区急性肺栓塞患者中的诊断价值. 青海医学院学报, 2016, 37(3): 145-149.
[18]	18. Zhou X, Wen W, Shan X, et al. MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism. Thromb Res, 2016, 138: 91-95.
[19]	19. Kessler T, Erdmann J, Vilne B, et al. Serum microRNA-1233 is a specific biomarker for diagnosing acute pulmonary embolism. J Transl Med, 2016, 14(1): 120.
[20]	20. Qin J, Liang H, Shi D, et al. A panel of microRNAs as a new biomarkers for the detection of deep vein thrombosis. J Thromb Thrombolysis, 2015, 39(2): 215-221.
[21]	21. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol, 2008, 26(4): 462-469.
[22]	22. Asaga S, Hoon DS. Direct serum assay for microRNA in cancer patients. Methods Mol Biol, 2013, 1024: 147-155.

Full-Text